ALLO Allogene Therapeutics, Inc.
Nasdaq · SEC CIK 1737287 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $666.4K 15 sales by 6 insiders
- Filings on record
- 144 since 2021-07-16, latest 2026-08-25 16:43
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Chang David D | Pres, CEO, Dir | — | $289.5K |
| Roberts Zachary | EVP of R, D | — | $104.2K |
| Douglas Earl Martin | SVP, GC | — | $103.3K |
| Parker Geoffrey M. | CFO | — | $88.5K |
| Beneski Benjamin Machinas | SVP, Chief Technical Off | — | $51.7K |
| Yoshiyama Annie | SVP, Fin | — | $29.3K |
| Kazam Joshua A | Dir | — | — |
Transactions 122
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-25 | 2022-03-23 | ALLO | SCHMIDT ERIC THOMAS | CFO | A - Grant | $0.00 | +237.4K | 337.9K | +236% | $0 |
| D | 2022-03-25 | 2022-03-23 | ALLO | Bhavnagri Veer | GC | A - Grant | $0.00 | +175.4K | 589.3K | +42% | $0 |
| D | 2022-03-25 | 2022-03-23 | ALLO | Amado Rafael | CMO, EVP of R, D | A - Grant | $0.00 | +237.4K | 557.5K | +74% | $0 |
| 2022-03-17 | 2022-03-15 | ALLO | Chang David D | Pres, CEO, Dir | S - Sale | $7.65 | -23.6K | 2.29M | -1% | -$180.9K | |
| 2022-03-17 | 2022-03-15 | ALLO | SCHMIDT ERIC THOMAS | CFO | S - Sale | $7.63 | -11.5K | 100.5K | -10% | -$87.5K | |
| 2022-03-17 | 2022-03-15 | ALLO | Amado Rafael | CMO, EVP of R, D | S - Sale | $7.71 | -5,169 | 320.1K | -2% | -$39.9K | |
| 2022-03-17 | 2022-03-15 | ALLO | Bhavnagri Veer | GC | S - Sale | $7.68 | -8,849 | 413.8K | -2% | -$68.0K | |
| 2022-03-17 | 2022-03-15 | ALLO | MOORE ALISON | Chief Technical Off | S - Sale | $7.63 | -8,698 | 120.4K | -7% | -$66.4K | |
| 2022-03-09 | 2022-03-07 | ALLO | Kazam Joshua A | Dir | J - Other | $0.00 | +412.6K | 671.5K | +159% | $0 | |
| 2022-03-09 | 2022-03-07 | ALLO | Kazam Joshua A | Dir | G - Gift | $0.00 | -412.6K | 258.9K | -61% | $0 | |
| I | 2022-01-14 | 2022-01-12 | ALLO | Belldegrun Arie | Dir | P - Purchase | $12.60 | +155.0K | 195.0K | +388% | +$1.95M |
| 2022-01-14 | 2022-01-12 | ALLO | Kazam Joshua A | Dir | P - Purchase | $12.60 | +15.0K | 258.9K | +6% | +$189.0K | |
| 2021-10-04 | 2021-10-01 | ALLO | Amado Rafael | CMO, EVP of R, D | S - Sale | $24.35 | -11.5K | 323.9K | -3% | -$280.2K | |
| D | 2021-09-17 | 2021-09-15 | ALLO | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.7K | +1% | +$11.3K |
| D | 2021-09-17 | 2021-09-15 | ALLO | Bhavnagri Veer | GC | S - Sale+OE | $24.77 | -5,000 | 421.7K | -1% | -$123.8K |
| 2021-09-09 | 2021-09-09 | ALLO | WITTE OWEN N. | Dir | S - Sale | $25.54 | -5,000 | 221.2K | -2% | -$127.7K | |
| M | 2021-08-23 | 2021-08-20 | ALLO | WITTE OWEN N. | Dir | S - Sale | $23.47 | -10.0K | 231.2K | -4% | -$234.7K |
| D | 2021-08-17 | 2021-08-16 | ALLO | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.4K | +1% | +$11.3K |
| D | 2021-08-17 | 2021-08-16 | ALLO | Bhavnagri Veer | GC | S - Sale+OE | $21.00 | -5,000 | 421.4K | -1% | -$105.0K |
| D | 2021-08-03 | 2021-07-30 | ALLO | SATO VICKI L | Dir | A - Grant | $0.00 | +19.4K | 19.4K | New | $0 |
| D | 2021-07-16 | 2021-07-15 | ALLO | Bhavnagri Veer | GC | S - Sale+OE | $21.55 | -5,000 | 421.4K | -1% | -$107.8K |
| D | 2021-07-16 | 2021-07-15 | ALLO | Bhavnagri Veer | GC | M - OptEx | $2.27 | +5,000 | 426.4K | +1% | +$11.3K |
Purchase Sale Sale after option exercise All abbreviations